pharma · Female Infertility · Breast Feeding
Abbott Pathology
Abbott Australasia Pty Ltd
Abbott Pathology clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Mile End, AU
- Founded
- 2001
- Employees
- 41
- Programs
- 6
- Drugs
- 9
- Patents
- 0
Abbott Pathology projects
6 ClinicalTrials.gov programs sponsored by Abbott Pathology.
Abbott Pathology has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Dydrogesterone 30 mg
Abbott Australasia Pty Ltd
Female Infertility
1 trial -
ZoMaxx™ Drug-Eluting Coronary Stent System
Abbott Australasia Pty Ltd
Coronary Disease
1 trial -
nutritional supplement
Abbott Australasia Pty Ltd
Children
1 trial -
Ritonavir
Abbott Australasia Pty Ltd
Sarcoma, Kaposi
1 trial -
Zemplar (paricalcitol ) capsules
Abbott Australasia Pty Ltd
Diabetic Nephropathy
1 trial -
Maternal Nutritional Supplement
Abbott Australasia Pty Ltd
Breast Feeding
1 trial
Frequently asked questions
How many clinical projects does Abbott Pathology have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.